Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 1547-1552, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruns, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruns, D. E.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Arnold O. Beckman Conference
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 2001;47:1547-1552.)
© 2001 American Association for Clinical Chemistry, Inc.


Proceedings of the 24th Arnold O. Beckman Conference

Laboratory-related Outcomes in Healthcare

David E. Bruns1

1 Department of Pathology, Box 800214, University of Virginia, Charlottesville, VA 22908. Fax 804-979-7599; e-mail dbruns{at}virginia.edu.


Abstract

Outcomes studies, long common on the therapeutic side of medicine, are appearing in the diagnostic arena. Outcomes can be defined as results of medical interventions (therapies or tests) in terms of health or cost. The studies of outcomes are important because funding for medical interventions increasingly depends on them; a major accrediting agency even defines "quality" entirely in terms of outcomes.

The study of laboratory-related outcomes is complex. Multiple steps occur between testing and outcomes, physicians act unpredictably on test results, and outcomes studies have high costs relative to potential profit from the test. Study design often must specify the action that is to follow a test result.

The model outcomes study is a randomized controlled trial (RCT). The CONSORT statement, which is used as a guideline for RCTs of therapies, is largely applicable to studies of diagnostic interventions. Recent laboratory-related RCTs have addressed questions such as: "Does routine testing before cataract surgery decrease morbidity or mortality?" and "Does fecal occult bleed testing decrease the incidence of colorectal cancer?"

RCTs of tests are sometimes impractical. Other approaches include simulation modeling and the use of intervention and control periods of testing. As for RCTs, these approaches require careful attention to study design, data analysis, and interpretation and reporting of results.




The following articles in journals at HighWire Press have cited this article:


Home page
BMJHome page
P. M Bossuyt, L. Irwig, J. Craig, and P. Glasziou
Comparative accuracy: assessing new tests against existing diagnostic pathways.
BMJ, May 6, 2006; 332(7549): 1089 - 1092.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
W. P. Oosterhuis, D. E. Bruns, J. Watine, S. Sandberg, and A. R. Horvath
Evidence-Based Guidelines in Laboratory Medicine: Principles and Methods
Clin. Chem., May 1, 2004; 50(5): 806 - 818.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.